NO172643C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivaterInfo
- Publication number
- NO172643C NO172643C NO893198A NO893198A NO172643C NO 172643 C NO172643 C NO 172643C NO 893198 A NO893198 A NO 893198A NO 893198 A NO893198 A NO 893198A NO 172643 C NO172643 C NO 172643C
- Authority
- NO
- Norway
- Prior art keywords
- benzopyranol
- derivatives
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23009488A | 1988-08-09 | 1988-08-09 | |
US07/367,082 US5015661A (en) | 1988-08-09 | 1989-06-16 | Chromanes and their pharmaceutical compositions and methods |
Publications (4)
Publication Number | Publication Date |
---|---|
NO893198D0 NO893198D0 (no) | 1989-08-08 |
NO893198L NO893198L (no) | 1990-02-12 |
NO172643B NO172643B (no) | 1993-05-10 |
NO172643C true NO172643C (no) | 1993-08-18 |
Family
ID=26923917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO893198A NO172643C (no) | 1988-08-09 | 1989-08-08 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater |
Country Status (13)
Country | Link |
---|---|
US (1) | US5015661A (fr) |
EP (1) | EP0354508A3 (fr) |
JP (1) | JPH0283379A (fr) |
KR (1) | KR900003175A (fr) |
AU (1) | AU616039B2 (fr) |
DK (1) | DK389089A (fr) |
HU (1) | HU206204B (fr) |
IL (1) | IL91245A0 (fr) |
MC (1) | MC2050A1 (fr) |
NO (1) | NO172643C (fr) |
NZ (1) | NZ230233A (fr) |
PH (1) | PH27235A (fr) |
PT (1) | PT91400A (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1305480C (fr) * | 1987-03-20 | 1992-07-21 | Roshantha A.S. Chandraratna | Acetylenes disubstitues portant des groupes heteroaromatiques et heterobicycliques a activite retinoidale |
FR2676056B1 (fr) * | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
US5149703A (en) * | 1991-09-06 | 1992-09-22 | Merck Frosst Canada, Inc. | Quinoline-substituted chromans and related compounds as leukotriene antagonists |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
US5451603A (en) * | 1993-03-11 | 1995-09-19 | Zymogenetics, Inc. | 3,4-diarylchromans for treatment of dermatitis |
KR960701033A (ko) * | 1993-12-08 | 1996-02-24 | 그레그 씨.브라운 | 효능있는 칼슘 길항 및 산화방지 활성을 모두 갖는 화합물, 및 세포보호제로서 그것의 사용방법(compounds having both potent calcium antagonist and antioxidant activity and use there of as cytoprotective agents) |
US5747528A (en) * | 1996-02-21 | 1998-05-05 | Warner-Lambert Company | Chroman derivatives as anti-oxidants |
ITTO20030140U1 (it) * | 2003-09-16 | 2005-03-17 | Interfila Srl | Matita cosmetica |
WO2005032544A1 (fr) * | 2003-09-19 | 2005-04-14 | Galileo Pharmaceuticals, Inc. | Traitement de maladies mitochondriales |
BRPI0519013A2 (pt) * | 2004-12-13 | 2009-11-03 | Lilly Co Eli | composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto |
WO2006093548A1 (fr) | 2005-02-25 | 2006-09-08 | Galileo Pharmaceuticals, Inc. | Chromans, thiochromans et dihydroquinolines heterocycliques |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
US4681890A (en) * | 1984-10-30 | 1987-07-21 | Kuraray Co., Ltd. | 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same |
EP0183869B1 (fr) * | 1984-12-06 | 1991-04-17 | Kuraray Co., Ltd. | Composés de chromane et leur utilisation |
JPS61148173A (ja) * | 1984-12-20 | 1986-07-05 | Kuraray Co Ltd | 新規なアミン及びその塩 |
DK173350B1 (da) * | 1985-02-26 | 2000-08-07 | Sankyo Co | Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem |
JPS61204122A (ja) * | 1985-03-07 | 1986-09-10 | Kuraray Co Ltd | 肝臓疾患治療剤 |
JPS61210030A (ja) * | 1985-03-13 | 1986-09-18 | Agency Of Ind Science & Technol | 抗腫瘍剤 |
JPS61267570A (ja) * | 1985-05-20 | 1986-11-27 | Kuraray Co Ltd | 3,4―ジヒドロ―2h―ベンゾピラン誘導体及びこれを有効成分とする利胆剤 |
JPS61267571A (ja) * | 1985-05-20 | 1986-11-27 | Kuraray Co Ltd | 2−(4−クロルフエノキシ)−2−メチルプロピオン酸エステル及びこれを有効成分とする血中脂質低下剤 |
JPS62132879A (ja) * | 1985-12-05 | 1987-06-16 | Kuraray Co Ltd | 3,4−ジヒドロ−2h−ベンゾピラン誘導体類及びこれを有効成分とする抗アレルギ−剤 |
US4824971A (en) * | 1986-01-23 | 1989-04-25 | Hoffman-La Roche Inc. | 2-allylchromans |
US4752646A (en) * | 1986-01-23 | 1988-06-21 | Hoffmann-La Roche Inc. | 2-halochromans |
WO1987005020A1 (fr) * | 1986-02-21 | 1987-08-27 | Kuraray Co., Ltd. | Derives de 3,4-dihydro-2h-benzopyranne et leur usage medicinal |
US4879395A (en) * | 1987-03-27 | 1989-11-07 | Hoffmann-La Roche Inc. | Vitamin E intermediate |
US4831185A (en) * | 1987-12-18 | 1989-05-16 | Hoffmann-La Roche Inc. | Asymmetric synthesis of natural vitamin E |
US4914217A (en) * | 1987-12-18 | 1990-04-03 | Hoffmann-La Roche Inc. | Asymmetric synthesis of natural vitamin E |
-
1989
- 1989-06-16 US US07/367,082 patent/US5015661A/en not_active Expired - Fee Related
- 1989-08-07 HU HU893980A patent/HU206204B/hu not_active IP Right Cessation
- 1989-08-07 NZ NZ230233A patent/NZ230233A/en unknown
- 1989-08-07 EP EP19890114523 patent/EP0354508A3/fr not_active Withdrawn
- 1989-08-07 MC MC892067A patent/MC2050A1/fr unknown
- 1989-08-08 PT PT198991400A patent/PT91400A/pt unknown
- 1989-08-08 AU AU39418/89A patent/AU616039B2/en not_active Ceased
- 1989-08-08 KR KR1019890011280A patent/KR900003175A/ko not_active Application Discontinuation
- 1989-08-08 DK DK389089A patent/DK389089A/da not_active Application Discontinuation
- 1989-08-08 PH PH39069A patent/PH27235A/en unknown
- 1989-08-08 IL IL91245A patent/IL91245A0/xx unknown
- 1989-08-08 NO NO893198A patent/NO172643C/no unknown
- 1989-08-09 JP JP1204905A patent/JPH0283379A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
HUT52493A (en) | 1990-07-28 |
NO172643B (no) | 1993-05-10 |
HU206204B (en) | 1992-09-28 |
JPH0283379A (ja) | 1990-03-23 |
PT91400A (pt) | 1990-03-08 |
US5015661A (en) | 1991-05-14 |
EP0354508A2 (fr) | 1990-02-14 |
JPH0579072B2 (fr) | 1993-11-01 |
DK389089A (da) | 1990-02-10 |
NO893198L (no) | 1990-02-12 |
AU3941889A (en) | 1990-02-15 |
IL91245A0 (en) | 1990-03-19 |
NZ230233A (en) | 1992-03-26 |
EP0354508A3 (fr) | 1991-03-27 |
MC2050A1 (fr) | 1990-07-17 |
AU616039B2 (en) | 1991-10-17 |
NO893198D0 (no) | 1989-08-08 |
KR900003175A (ko) | 1990-03-23 |
DK389089D0 (da) | 1989-08-08 |
PH27235A (en) | 1993-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO172801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater | |
NO171506C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater | |
NO168770C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO172540C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrrolderivater | |
NO170629C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater | |
NO169014C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive distamycinderivater | |
NO171507C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater | |
NO169438C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser | |
NO167026C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO171856C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater | |
NO172489C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
NO168299C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater | |
NO172539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser | |
NO170021C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater | |
NO171857C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater | |
NO172643C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater | |
NO170582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser | |
NO173061C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner | |
NO173185C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser | |
NO169069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater | |
NO169007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater | |
NO167284C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksazol- og isoksazolderivater. | |
NO172802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner | |
NO171847C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater | |
NO169648C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater |